CNE000000WF9
CNE000000WF9
BEIJING TIANTAN BIOLOGICAL PROD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 25.17B EUR | 22.9B EUR | 29.88B EUR | 32.31B EUR |
Enterprise Value | 26.79B EUR | 20.88B EUR | 28.08B EUR | 30.48B EUR |
Valuation Multiples | ||||
Trailing P/E | 33.5x | 40.1x | 37.99x | 35.71x |
Forward P/E | 30.91x | -- | -- | -- |
Price to Sales | 4.45x | 5.33x | 6.44x | 6.71x |
Price to Book | 2.11x | 1.92x | 2.52x | 2.75x |
EV/Revenue | 4.74x | 4.86x | 6.05x | 6.33x |
EV/EBITDA | 16.11x | 19.94x | 20.46x | 19.28x |
Price to FCF (P/FCF) | 77.61x | 1,570.11x | -- | -- |
EV/FCF | 82.59x | 1,431.9x | -- | -- |
FCF Yield | 1.29% | 0.06% | -0.73% | -1.43% |